From: Orthorexia Nervosa: differences between clinical and non-clinical samples
 | AN/BN (n = 90) M (SD) 1 | Obesity/BED (n = 54) M (SD) 2 | Diet (n = 91) M (SD) 3 | Control (n = 94) M (SD) 4 | F or CHI and sign (p) | Partial η2 | Bonferroni post-hoc comparison (p) |
---|---|---|---|---|---|---|---|
Age (years) | 27.52 (10.58) | 53.78 (14.47) | 45.89 (12.71) | 24.60 (5.08) | 126.23(3) (<.001) | .54 | 2 > 1;3;4 (<.001) 3 > 1;4 (<.001) |
School Years | 14.61 (3.17) | 13.09 (3.70) | 14.23 (3.27) | 16.72 (2.33) | 18.67(3) (<.001) | .15 | 1 > 2 (<.05) 4 > 1;2;3 (<.001) |
BMI (SD) | 18.16 (5.09) | 38.86 (7.31) | 24.78 (5.53) | 21.04 (3.17) | 194.55(3) (<.001) | .65 | 2 > 1;3;4 (<.001) 3 > 1;4 (<.001) 4 > 1 (<.001) |
Gender Female n (%) | 89 (98.9%) | 37 (68.5%) | 48 (52.7%) | 90 (95.7%) | 82.06(3) (<.001) | – | – |
Diagnosis | AN n(%) = 69 (76.67%) BN n (%) = 21 (23.33%) | Obesity n (%) = 31 (57.41%) Obesity+BED n (%) = 23 (42.59%) | NA | NA | – | – | – |
Comorbidity Yes n (%) | 28 (30.77%) | 28 (51.85%) | NA | NA | – | – | – |
Psychotropic Drug Yes n (%) | 62 (69.23%) | 29 (53.7%) | 3 (3.19%) | NA | – | – | – |